Vous êtes sur la page 1sur 2

3724 Federal Register / Vol. 70, No.

16 / Wednesday, January 26, 2005 / Notices

128–1996/1–US–01); to Apogenix T cell responses, including apoptosis, as SW., Washington, DC 20593–0001.


Biotechnology AG, having a place of a means of treating MS. Please bring a government-issued ID
business in Heidelberg, Germany. The The prospective exclusive license will with photo (e.g., driver’s license). Send
patent rights in these inventions have be royalty-bearing and will comply with written material and requests to make
been assigned to the United States of the terms and conditions of 35 U.S.C. oral presentations to Mr. Gerald Miante,
America. 209 and 37 CFR 404.7. The prospective Commandant (G–MSO–1), U.S. Coast
The prospective exclusive license exclusive license may be granted unless Guard Headquarters, 2100 Second Street
territory will be worldwide and the field within sixty (60) days from the date of SW., Washington, DC 20593–0001. This
of use may be limited to therapeutics for this published notice, the NIH receives notice and related documents are
the treatment of Multiple Sclerosis. written evidence and argument that available on the Internet at http://
DATES: Only written comments and/or
establish that the grant of the license dms.dot.gov under the docket number
license applications which are received would not be consistent with the USCG–2005–20120.
by the National Institutes of Health on requirements of 35 U.S.C. 209 and 37
CFR 404.7. FOR FURTHER INFORMATION CONTACT: Mr.
or before March 28, 2005, will be Gerald Miante, Assistant Executive
Applications for a license in the field
considered. Director of TSAC, telephone 202–267–
of use filed in response to this notice
ADDRESSES: Requests for copies of the will be treated as objections to the grant 0214, fax 202–267–4570, or e-mail
patent and/or patent applications, of the contemplated exclusive license. gmiante@comdt.uscg.mil.
inquiries, comments and other materials Comments and objections submitted to SUPPLEMENTARY INFORMATION: Notice of
relating to the contemplated exclusive this notice will not be made available these meetings is given under the
license should be directed to: Mojdeh for public inspection and, to the extent Federal Advisory Committee Act, 5
Bahar, J.D., Technology Licensing permitted by law, will not be released U.S.C. App. 2 (Pub. L. 92–463, 86
Specialist, Office of Technology under the Freedom of Information Act, Stat.770, as amended).
Transfer, National Institutes of Health, 5 U.S.C. 552.
6011 Executive Boulevard, Suite 325, Agenda of Working Group Meetings
Dated: January 19, 2005.
Rockville, MD 20852–3804; Telephone: The agenda for the Towing Vessel
Steven M. Ferguson,
(301) 435–2950; Facsimile: (301) 402– Inspection Working Group tentatively
Director, Division of Technology Development
0220; E-mail: baharm@od.nih.gov. includes the following items:
and Transfer, Office of Technology Transfer,
SUPPLEMENTARY INFORMATION: The National Institutes of Health. (1) Identify and discuss the elements
technology claimed in the [FR Doc. 05–1413 Filed 1–25–05; 8:45 am] that would comprise a safety
aforementioned patents is a method for BILLING CODE 4140–01–P
management system for use in towing
the treatment or prevention of vessel inspection program including
autoimmune diseases, allergic or atopic audit, oversight and enforcement of this
disorders, and graft rejections. The DEPARTMENT OF HOMELAND safety management system.
instant method comprises inducing the SECURITY (2) Identify and discuss equipment
death by apoptosis of a subpopulation of standards appropriate for a towing
T lymphocytes that is capable of causing Coast Guard vessel inspection program including use
such diseases, while leaving the of existing standards and incorporation
majority of other T lymphocytes [USCG–2005–20120]
of new standards.
unaffected. Cell death is achieved by Towing Safety Advisory Committee (3) Identify and discuss the use of a
cycles comprising challenging via risk-based approach incorporating
immunization these T cells with AGENCY: Coast Guard, DHS. available casualty data and other input
antigenic substance at short time ACTION: Notice of meetings. to develop and support working group
intervals, or by immunization followed proposals.
by administering interleukin-2 (IL–2) SUMMARY: The Towing Vessel Inspection
when these T cells are expressing high Working Group of the Towing Safety Procedural
levels of IL–2 receptor so as to cause Advisory Committee (TSAC) will meet The meetings are open to the public.
these T cells to undergo apoptosis upon to discuss matters relating to these Please note that the meetings may close
re-immunization with the antigenic specific issues of towing safety. The early if all business is finished. At the
peptide or protein. meetings will be open to the public. Chair’s discretion, members of the
The technologies in the DATES: The Towing Vessel Inspection public may make oral presentations
aforementioned patent applications are Working Group will meet on during the meeting. If you would like to
directed to compositions and methods Wednesday, March 2, 2005 from 1:30 make an oral presentation at the
for clinical assessment, diagnosis and p.m. to 4:30 p.m. and on Thursday, meeting, please notify the Assistant
treatment of Multiple Sclerosis (MS). March 3, 2005 from 8:30 a.m. to 2 p.m. Executive Director (as provided above in
The compositions are molecules related The meetings may close early if all for further information contact) no later
to the human proteolipid protein (PLP), business is finished. Written material than February 18, 2005. Written
and the 21.5 kDA fetal isoform of and requests to make oral presentations material for distribution at the meeting
human myelin basic protein (MBP), and should reach the Coast Guard on or should reach the Coast Guard no later
include nucleic acids and polypeptides. before February 18, 2005. Requests to than February 18, 2005.
The nucleic acids are useful in the have a copy of your material distributed
to each member of the Working Group Information on Services for Individuals
efficient production of modified PLP
should reach the Coast Guard on or with Disabilities
polypeptides and modified and
unmodified MBP polypeptides and the before February 18, 2005. For information on facilities or
polypeptides are useful for assaying T ADDRESSES: The Working Group will services for individuals with disabilities
cells for responsiveness to MBP and PLP meet in the 4th Floor All-Hands or to request special assistance at the
epitopes. They are further useful as Conference Room (#4202), U.S. Coast meeting, contact Mr. Miante at the
therapeutic agents that act by inducing Guard Headquarters, 2100 Second Street number listed in FOR FURTHER

VerDate jul<14>2003 19:33 Jan 25, 2005 Jkt 205001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1
Federal Register / Vol. 70, No. 16 / Wednesday, January 26, 2005 / Notices 3725

INFORMATION CONTACT as soon as corporations, and the interest rate for behalf of the Secretary of the Treasury
possible. underpayments will be 5 percent. This on a quarterly basis. The rates effective
Dated: January 18, 2005. notice is published for the convenience for a quarter are determined during the
Howard L. Hime,
of the importing public and Customs first-month period of the previous
and Border Protection personnel. quarter.
Acting Director of Standards, Marine Safety,
Security and Environmental Protection. EFFECTIVE DATE: January 1, 2005. In Revenue Ruling 2004–111, the IRS
[FR Doc. 05–1422 Filed 1–25–05; 8:45 am] FOR FURTHER INFORMATION CONTACT: determined the rates of interest for the
BILLING CODE 4910–15–P Trong Quan, National Finance Center, calendar quarter beginning January 1,
Collections Section, 6026 Lakeside 2005, and ending March 31, 2005. The
Boulevard, Indianapolis, Indiana 46278; interest rate paid to the Treasury for
DEPARTMENT OF HOMELAND telephone (317) 614–4516. underpayments will be the Federal
SECURITY SUPPLEMENTARY INFORMATION: short-term rate (2%) plus three
percentage points (3%) for a total of five
Customs and Border Protection Background percent (5%). For corporate
Pursuant to 19 U.S.C. 1505 and overpayments, the rate is the Federal
Quarterly IRS Interest Rates Used in Treasury Decision 85–93, published in short-term rate (2%) plus two
Calculating Interest on Overdue the Federal Register on May 29, 1985 percentage points (2%) for a total of four
Accounts and Refunds on Customs (50 FR 21832), the interest rate paid on percent (4%). For overpayments made
Duties applicable overpayments or by non-corporations, the rate is the
AGENCY: Customs and Border Protection, underpayments of customs duties must Federal short-term rate (2%) plus three
Department of Homeland Security. be in accordance with the Internal percentage points (3%) for a total of five
Revenue Code rate established under 26 percent (5%). These interest rates are
ACTION: General notice.
U.S.C. 6621 and 6622. Section 6621 was subject to change for the calendar
SUMMARY: This notice advises the public amended (at paragraph (a)(1)(B) by the quarter beginning April 1, 2005, and
of the quarterly Internal Revenue Internal Revenue Service Restructuring ending June 30, 2005.
Service interest rates used to calculate and Reform Act of 1998, Public Law For the convenience of the importing
interest on overdue accounts 105–206, 112 Stat. 685) to provide public and Customs and Border
(underpayments) and refunds different interest rates applicable to Protection personnel the following list
(overpayments) of customs duties. For overpayments: one for corporations and of IRS interest rates used, covering the
the calendar quarter beginning January one for non-corporations. period from before July of 1974 to date,
1, 2005, the interest rates for The interest rates are based on the to calculate interest on overdue
overpayments will be 4 percent for Federal short-term rate and determined accounts and refunds of customs duties,
corporations and 5 percent for non- by the Internal Revenue Service (IRS) on is published in summary format.

Corporate
Underpay- Overpay- overpay-
Beginning date Ending date ments ments ments (eff.
(percent) (percent) 1–1–99)
(percent)

070174 .................................................................. 063075 .................................................................. 6 6


070175 .................................................................. 013176 .................................................................. 9 9
020176 .................................................................. 013178 .................................................................. 7 7
020178 .................................................................. 013180 .................................................................. 6 6
020180 .................................................................. 013182 .................................................................. 12 12
020182 .................................................................. 123182 .................................................................. 20 20
010183 .................................................................. 063083 .................................................................. 16 16
070183 .................................................................. 123184 .................................................................. 11 11
010185 .................................................................. 063085 .................................................................. 13 13
070185 .................................................................. 123185 .................................................................. 11 11
010186 .................................................................. 063086 .................................................................. 10 10
070186 .................................................................. 123186 .................................................................. 9 9
010187 .................................................................. 093087 .................................................................. 9 8
100187 .................................................................. 123187 .................................................................. 10 9
010188 .................................................................. 033188 .................................................................. 11 10
040188 .................................................................. 093088 .................................................................. 10 9
100188 .................................................................. 033189 .................................................................. 11 10
040189 .................................................................. 093089 .................................................................. 12 11
100189 .................................................................. 033191 .................................................................. 11 10
040191 .................................................................. 123191 .................................................................. 10 9
010192 .................................................................. 033192 .................................................................. 9 8
040192 .................................................................. 093092 .................................................................. 8 7
100192 .................................................................. 063094 .................................................................. 7 6
070194 .................................................................. 093094 .................................................................. 8 7
100194 .................................................................. 033195 .................................................................. 9 8
040195 .................................................................. 063095 .................................................................. 10 9
070195 .................................................................. 033196 .................................................................. 9 8
040196 .................................................................. 063096 .................................................................. 8 7
070196 .................................................................. 033198 .................................................................. 9 8
040198 .................................................................. 123198 .................................................................. 8 7
010199 .................................................................. 033199 .................................................................. 7 7 6
040199 .................................................................. 033100 .................................................................. 8 8 7

VerDate jul<14>2003 19:33 Jan 25, 2005 Jkt 205001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1

Vous aimerez peut-être aussi